Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study

詳細情報 詳細情報について

• CRID

  1362825895247103232

• DOI

  10.1093/annonc/mdx339

• ISSN

  09237534

• Web Site

  https://api.elsevier.com/content/article/PII:S0923753419349439?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0923753419349439?httpAccept=text/plain

  http://academic.oup.com/annonc/article-pdf/28/10/2581/25113639/mdx339.pdf

• データソース種別

  • Crossref